Trials / Completed
CompletedNCT04409015
ROTEM® Obstetric Hemorrhage Pilot Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective observational study among women at high-risk of postpartum hemorrhage, in their third trimester who are admitted to Labor \&Delivery in spontaneous labor, for induction of labor, or for scheduled cesarean section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ROTEM - rotation thromboelastometry testing | The ROTEM® is a simple blood test that provides information about specific components involved in blood clotting and stopping hemorrhage. |
Timeline
- Start date
- 2020-07-27
- Primary completion
- 2021-01-30
- Completion
- 2022-03-01
- First posted
- 2020-06-01
- Last updated
- 2022-09-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04409015. Inclusion in this directory is not an endorsement.